Treatabolome Project Designed to Shorten Diagnosis-to-Treatment Time for Patients with Rare Diseases
The NMD4C would like to share the publication of a special issue of the Journal of Neuromuscular Diseases dedicated to the Treatabolome, a new online database for rare disease and gene-specific treatment information. The special issue includes six systematic reviews contributed by experts on rare neurological disorders.
You can access the special issue of the Journal of Neuromuscular Disease here.
The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise. Developed under the Solve-RD European Research Project, it is intended to reduce treatment delays for patients with rare diseases by directly linking diagnosis and treatment information. This initiative is highly relevant to neuromuscular disorders as they are rare diseases by definition. In this special issue of the Journal of Neuromuscular Diseases, experts contribute Treatabolome-feeding systematic literature reviews on rare neurological and neuromuscular disorders.
Read more about the Treatabolome project here.
Read next...
Sixth Annual NMD4C and MDC Clinical Fellowship Competition from Opens May 1st
Together, NMD4C and MDC are excited to open our 2027 annual funding competition to provide clinical fellowship award(s) in neuromuscular medicine and electromyography (EMG)! This annual funding competition provides one-year salary support ($80,000) for early-career clinicians to participate in Canadian neuromuscular medicine and EMG fellowship training programs.
Advancing Neuromuscular Research: MDC Awards $700k to Seven NMD4C Investigator-Led Projects
We’re proud to share that neuromuscular research led by our NMD4C Investigators and Leads; Dr. Hanns Lochmüller, Dr. Rashmi Kothary, Dr. Rami Massie, Dr. Elise Duchesne, Dr. Omid Kiamanesh, and Dr. Nicolas Dumont, have been recognized in Muscular Dystrophy Canada’s 2026 Neuromuscular Clinical and Translational Research Grant announcement. Drawing from MDC’s national funding update, we’re…
Announcing the 2026 NMD4C Award Recipients
We are excited to announce the recipients of the 2026 NMD4C Awards, recognizing excellence, leadership, and impact across Canada’s neuromuscular research community. In this fourth cycle, the program introduces two new award categories, and expand on our ability to celebrate the work of contributions of trainees and patient partners who strengthen our national network.